SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Grace Therapeutics, Inc. (GRCE) News

Follow Grace Therapeutics, Inc. (GRCE) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol GRCE Asset equity Sector Markets 90 days 4 Last 1.86 Updated Sep 03, 2026, 12:07 PM UTC Open live news feed Open GRCE chart & news
L Grace Therapeutics to participate in H.C. Wainright global investment conference Grace Therapeutics, Inc. (NASDAQ:GRCE) said it will participate in the H.C. Wainright 28th Annual Global Investment Conference. EQUITY | Sep 03, 2026, 12:07 PM UTC L Grace Therapeutics to participate in H.C. Wainright conference Grace Therapeutics (GRCE) will participate in the H.C. Wainright 28th Annual Global Investment Conference. EQUITY | Sep 03, 2026, 12:01 PM UTC L NBIS closes $5.75 billion private convertible note offering NBIS closes a private offering of convertible senior notes with aggregate gross proceeds of approximately $5.75 billion, while multiple other companies file shelf and registration statements. EQUITY | Aug 25, 2026, 09:46 AM UTC L GRCE files Form S-3 for up to 4,761,904 shares GRCE files a Form S-3 registration statement for up to 4,761,904 shares of common stock. REGULATION | Aug 24, 2026, 08:10 PM UTC L Grace Therapeutics reports first-quarter 2027 financial results Grace Therapeutics announces first-quarter 2027 financial results and provides a business update. EARNINGS | Aug 13, 2026, 12:01 PM UTC H Grace Therapeutics Announces $10 Million Private Placement Grace Therapeutics raises $10 million EQUITY | Aug 05, 2026, 01:01 AM UTC L Grace Therapeutics receives Type A meeting minutes from FDA Grace Therapeutics... EQUITY | Jul 28, 2026, 11:12 AM UTC L 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Can Fite Biopharma (AMEX: CANF ) stock moved upwards by 52.0% to $4.52 during Wednesday's pre-market session. The company's market cap stands at $6.3 million. Atlantic International (NASDAQ: ATLN ) shares rose 17 EQUITY | Jul 01, 2026, 12:05 PM UTC